The Effect of MK0633 in Patients With Chronic Asthma (0633-007)

NCT00404313 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

688

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: MK0633
DRUG: Comparator: placebo

Sponsor

Merck Sharp & Dohme LLC